Leap Therapeutics Investor Relations Material
Latest events
Status Update
Leap Therapeutics
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Leap Therapeutics Inc
Access all reports
Leap Therapeutics Inc. is a clinical-stage biopharmaceutical company that focuses on developing novel therapeutics for cancer treatment. The company's main activities involve acquiring and developing antibody therapies, particularly targeting cancer-specific pathways and cell surface molecules, while also activating the immune system against cancer cells. Leap Therapeutics is engaged in multiple ongoing clinical trials for its lead product candidates. The company is headquartered in Cambridge, Massachusetts, and its shares are listed on the NASDAQ.
Key slides for Leap Therapeutics Inc
43rd Annual J.P. Morgan Healthcare Conference 2025
Leap Therapeutics Inc
Study Result
Leap Therapeutics Inc
Latest articles
)
The Fifteenth Generation: A Conversation with Pietro Gussalli Beretta
An interview with Pietro Gussalli Beretta on how Beretta Holding blends 500 years of tradition with global growth, innovation, and long-term vision.
10 Jul 2025
)
Citadel: Relentless Optimization at Global Scale
From a Harvard dorm to global dominance, this is the story of how Ken Griffin created one of the best-performing hedge funds of all time.
4 Jul 2025
)
David A. Ricks: Eli Lilly's Chairman and CEO
David Ricks built a decades-long career at Eli Lilly, now leading the giant company through a defining moment in its long pharmaceutical history.
3 Jul 2025
Ticker symbol
LPTX
Country
🇺🇸 United States